Lawrenceville, NJ, United States of America

Xiaoqi Xie


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014-2016

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Xiaoqi Xie in Prostate Cancer Research

Introduction

Xiaoqi Xie is a notable inventor based in Lawrenceville, NJ (US), recognized for his contributions to the field of cancer research. He holds two patents that focus on innovative methods for treating hormone-refractory prostate cancer. His work is significant in advancing medical treatments and improving patient outcomes.

Latest Patents

Xie’s latest patents include a groundbreaking invention that identifies E2F as a target for hormone-refractory prostate cancer. The invention provides amino acid sequences that compete with E2F for DNA binding. Additionally, it outlines methods for using these amino acid sequences in the treatment of hormone-refractory prostate cancer. This innovative approach has the potential to enhance therapeutic strategies in oncology.

Career Highlights

Xiaoqi Xie is affiliated with Rutgers, the State University of New Jersey, where he conducts his research. His academic and professional journey has been marked by a commitment to understanding and combating cancer, particularly in developing targeted therapies.

Collaborations

Xie collaborates with esteemed colleagues, including Joseph R. Bertino and Debabrata Banerjee. These partnerships enhance the research efforts and contribute to the advancement of cancer treatment methodologies.

Conclusion

Xiaoqi Xie’s work exemplifies the intersection of innovation and medical research, particularly in the fight against prostate cancer. His patents and collaborations reflect a dedication to improving treatment options for patients facing this challenging disease.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…